CEACAM1 and neoplasm: It is also expressed on the surface of several immune cell subsets, including macrophages, T lymphocytes, and NK cells, where homophilic interactions with the CEACAM1+ tumour cells abrogate NK-mediated cytotoxicity (Helfrich and Singer, 2019; Markel et al., 2002).